StageZero Life Sciences Ltd.
SZLSF
$0.0021
-$0.025-92.25%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 09/30/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -399.30K | -649.50K | -386.30K | -821.90K | -821.90K |
| Total Depreciation and Amortization | -16.70K | 43.80K | 18.30K | 38.10K | 38.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 111.50K | -65.90K | 64.90K | 152.40K | 152.40K |
| Change in Net Operating Assets | 314.80K | 608.60K | 210.20K | 679.20K | 679.20K |
| Cash from Operations | 10.30K | -62.90K | -92.90K | 47.80K | 47.80K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 110.00K | 136.80K | -- | -- |
| Total Debt Repaid | -15.90K | -31.90K | -64.70K | -116.70K | -116.70K |
| Issuance of Common Stock | -- | -- | -- | 28.70K | 28.70K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -15.90K | 78.10K | 72.10K | -87.90K | -87.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.70K | 15.20K | -20.80K | -40.10K | -40.10K |
